MetaCap

BioVie (BIVI) News

NASDAQ: BIVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.80-0.1098 (-12.07%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BIVI news summary

We found 7 recent headlines mentioning BioVie (BIVI): 1 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq, Business Insider. BIVI is making an outsized move today, down 12.07% at $0.80, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "BioVie Presents New Biomarker Data Highlighting Biomarker-Defined Endotypes and Neuropeptide Y Response to Bezisterim at the 4th Long COVID International Conference 2026", was published by GlobeNewswire on Nov 16, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest BioVie headlines

Stocks mentioned alongside BIVI

Compare BIVI